News archive

The CEO of Pila Pharma was recently interviewed by Vækstaktier, Denmark about his participation in BIO INTERNATIONAL CONVENTION 2024, the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.

Find the link to the article and other articles about Pila Pharma (in Danish) on Vækstaktier.dk

SEPT 06: Nordic Life Science Magazine:

Pila Pharma raises capital for international obesity study.

Read the report (in English) here

Sept 12: Børsen / Berlingske Tidende Tema:

Pila Pharma baner vejen for nye tanker om behandling af diabetes og fedme.

Read the report PDF (in Danish) here

SEPT 18: Svenska Dagbladet Tema: Innovation, Vård & Life Science:

Innovativt läkemedel för typ-2 diabetes och övervikt är nära.

Read the report (in Swedish) here

Aktie.info Danmark Analyse af Pila Pharma

2. analyse – Pila Pharma Halvårsrapport 2024 (September 30, 2024)

Read the report PDF (in Danish) here

Is Oral XEN-D0501 the Next Obesity Drug Hype? (December 20, 2024)

Read the article PDF (in English) here

Read the article on medscape.com (in English) here

Millionærklubben by EuroInvestor [14. November 2024]

CEO Gustav H. Gram participates in Denmark’s largest finance and investment podcast to elaborate on PILA PHARMA and discuss the emerging trends within the obesity and diabetes market.

Please, find the link to the video (in Danish) here

PILA PHARMA PUBLISHES THE ANNUAL REPORT 2024

The report in Swedish can be found here

Contact us